Living Medicines and Microbial Therapeutics Market - Strategic Insights and Forecasts (2026-2031)

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

1. 2.1. Market Overview

2. 2.2. Market Definition

3. 2.3. Scope of the Study

4. 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

1. 3.1. Market Drivers

2. 3.2. Market Restraints

3. 3.3. Market Opportunities

4. 3.4. Porter’s Five Forces Analysis

5. 3.5. Industry Value Chain Analysis

6. 3.6. Policies and Regulations

7. 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LIVING MEDICINES AND MICROBIAL THERAPEUTICS MARKET BY PRODUCT TYPE

1. 5.1. Introduction

2. 5.2. Live Biotherapeutic Products (LBPs)

3. 5.3. Probiotics

4. 5.4. Prebiotics

5. 5.5. Synbiotics

6. 5.6. Postbiotics

7. 5.7. Microbial Consortia

8. 5.8. Engineered Microbial Therapeutics

6. LIVING MEDICINES AND MICROBIAL THERAPEUTICS MARKET BY THERAPEUTIC APPLICATION

1. 6.1. Introduction

2. 6.2. Gastrointestinal Disorders

3. 6.3. Metabolic Diseases

4. 6.4. Infectious Diseases

5. 6.5. Autoimmune and Inflammatory Disorders

6. 6.6. Oncology Supportive Therapies

7. 6.7. Neurological & Psychiatric Conditions

8. 6.8. Rare Genetic Disorders

9. 6.9. Others

7. LIVING MEDICINES AND MICROBIAL THERAPEUTICS MARKET BY END USER

1. 7.1. Introduction

2. 7.2. Hospitals & Clinics

3. 7.3. Specialty Clinics

4. 7.4. Research & Diagnostic Laboratories

5. 7.5. Home Healthcare

6. 7.6. Others

8. LIVING MEDICINES AND MICROBIAL THERAPEUTICS MARKET BY GEOGRAPHY

1. 8.1. Introduction

2. 8.2. North America

   1. 8.2.1. USA

   2. 8.2.2. Canada

   3. 8.2.3. Mexico

3. 8.3. South America

   1. 8.3.1. Brazil

   2. 8.3.2. Argentina

   3. 8.3.3. Others

4. 8.4. Europe

   1. 8.4.1. United Kingdom

   2. 8.4.2. Germany

   3. 8.4.3. France

   4. 8.4.4. Spain

   5. 8.4.5. Others

5. 8.5. Middle East and Africa

   1. 8.5.1. Saudi Arabia

   2. 8.5.2. UAE

   3. 8.5.3. Others

6. 8.6. Asia Pacific

   1. 8.6.1. China

   2. 8.6.2. India

   3. 8.6.3. Japan

   4. 8.6.4. South Korea

   5. 8.6.5. Indonesia

   6. 8.6.6. Thailand

   7. 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

1. 9.1. Major Players and Strategy Analysis

2. 9.2. Market Share Analysis

3. 9.3. Mergers, Acquisitions, Agreements, and Collaborations

4. 9.4. Competitive Dashboard

10. COMPANY PROFILES

1. 10.1. Seres Therapeutics

2. 10.2. Vedanta Biosciences

3. 10.3. Rebiotix Inc.

4. 10.4. Finch Therapeutics

5. 10.5. 4D Pharma plc

6. 10.6. Synlogic

7. 10.7. Enterome

8. 10.8. Evelo Biosciences

9. 10.9. Microbiotica

10. 10.10. Second Genome

11. APPENDIX

1. 11.1. Currency

2. 11.2. Assumptions

3. 11.3. Base and Forecast Years Timeline

4. 11.4. Key benefits for the stakeholders

5. 11.5. Research Methodology

6. 11.6. Abbreviations